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Background: Oil body-associated allergens such as oleosins have been reported for important allergenic foods
such as peanut, sesame and hazelnut. Here we investigate whether oil body associated proteins (OAPs) are linked
with specific clinical phenotypes and whether they are represented in skin prick test (SPT) reagents.
Methods: A hazelnut OAP fraction was characterized by mass-spectrometry (MS) to identify its major constituents.
Polyclonal rabbit antibodies were generated against hazelnut OAPs. The presence of OAPs in commercially available
hazelnut SPTs was studied by immunoblot and spiking experiments. OAP-specific IgE antibodies were measured in
sera from patients with a convincing history of hazelnut allergy by RAST (n = 91), immunoblot (n = 22) and basophil
histamine release (BHR; n = 14).
Results: Hazelnut OAPs were analysed by MS and found to be dominated by oleosins at ~14 and ~17 kDa, and a
27 kDa band containing oleosin dimers and unidentified protein. In 36/91 sera specific IgE against hazelnut OAPs
was detected, and confirmed to be biologically active by BHR (n = 14). The majority (21/22) recognized the oleosin
bands at 17 kDa on immunoblot, of which 11 exclusively. These OAP-specific IgE responses dominated by oleosin
were associated with systemic reactions to hazelnut (OR 4.24; p = 0.015) and negative SPT (χ2 6.3, p = 0.012).
Immunoblot analysis using OAP-specific rabbit antiserum demonstrated that commercial SPT reagents are virtually
devoid of OAPs, sometimes (3/9) resulting in false-negative SPT. Spiking of SPT reagents with OAP restored serum
IgE binding of these false-negative patients on immunoblot at mainly 17 kDa.
Conclusion: Hazelnut allergens found in oil bodies dominated by oleosin are associated with more severe systemic
reactions and negative SPT. Defatted diagnostic extracts are virtually devoid of these allergens, resulting in poor
sensitivity for detection of IgE antibodies against these clinically relevant molecules.
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Food allergic reactions after hazelnut ingestion are fre-
quently observed [1,2]. In Central and Northern Europe,
allergy to hazelnut is mostly associated with birch-pollen
allergy and is almost exclusively mild and restricted to
the oral cavity [3]. Primary sensitization to the major
birch pollen allergen Bet v 1 results in cross-reactivity to* Correspondence: l.zuidmeer@amc.uva.nl
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article, unless otherwise stated.its homologue in hazelnut, Cor a 1[4,5]. Non-pollen re-
lated hazelnut allergy more frequently induces severe
systemic reactions which can already be observed in
young children that have not (yet) developed inhalant al-
lergies [6,7]. These severe reactions are the dominant
clinical presentation in areas without significant expos-
ure to birch pollen like Spain[8]. Non-pollen related al-
lergens that have been identified in hazelnut so far are
the non-specific lipid transfer protein (LTP), Cor a 8 [9]
and homologues of the major peanut allergens Ara h 1
(7S vicilin) Ara h 2 (2S albumin) and Ara h 3 (11SMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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14 and Cor a 9 respectively [10-12]. The latter two have
recently been demonstrated to be associated with more
severe objective symptoms in hazelnut allergy[11,13].
Although sufficient quantities of these water-soluble aller-
genic storage proteins are present in diagnostic reagents
[14], a substantial number of (tree)nut and seed-allergic pa-
tients is not diagnosed adequately using commercial SPT
and in vitro reagents ([15,16]; pers. communication G.
Lack). For Cor a 8, it has been reported that this allergen is
virtually absent in some commercial SPT reagents [17].
The low levels of LTP can be explained by the extraction
protocols used for peanut or hazelnut, which are commonly
carried out at neutral pH where LTPs are optimally soluble
at acidic pH [18,19]. Another characteristic of extraction
procedures used for legumes, seeds and nuts is that de-
fatting steps are included. These types of foods however
contain oil bodies. A major protein in oil bodies is oleosin,
a protein constituting around 10-20% of the total seed pro-
tein [20-22]. Oleosins are alkaline proteins (pI ± 10) with
molecular weights from 15 to 24 kDa [23], which stabilize
triacylglycerol containing oil bodies in the cytoplasm [22].
Oil bodies are an energy source for growth and germination
of seedlings. Oleosins are embedded in the oil body with a
highly conserved hydrophobic central domain [24], whereas
the hydrophilic alpha-helical N-terminus and amphipathic
alpha-helical C-terminus, which is conserved among many
oleosins [20-22], are in contact with the aqueous cytoplasm
[25].Oleosins have been identified as allergens in peanut,
sesame seed and hazelnut [16,26,27].
We hypothesize that patients with convincing (some-
times severe) hazelnut allergy but negative diagnostic
tests, may often have specific IgE antibodies against oil
body-associated proteins (OAPs) such as oleosins, al-
lergens that are largely removed from diagnostic food
extracts during de-fatting steps. The aim of this study
was to test commercially available skin prick test (SPT)
reagents with respect to the presence of OAPs, and to
use purified OAPs from hazelnut to evaluate the clinical
importance of OAP-specific IgE antibodies using sera
from well-characterized patients with a convincing his-
tory and/or positive DBPCFC for hazelnut. Immuno-
blot analysis in conjunction with mass spectrometry
was used to establish the role of oleosins as the major
allergenic components of OAPs.
Material and methods
Patients
We used a retrospectively collected panel of 91 sera of
patients with a convincing history of hazelnut ingestion-
related symptoms that were recruited via the outpatient
clinics of the University Medical Centre Utrecht (n =
53) and the Medical Centre Alkmaar (n = 13, The
Netherlands) and the Manchester Royal Infirmary (n =25, UK). All patients gave written informed consent for
using their serum for research purposes. The patients
from Utrecht were all collected in the framework of a
study on hazelnut allergy, and in 30/53 this was con-
firmed by DBPCFC [28]. The patients from Alkmaar
were collected in the framework of a collaboration be-
tween Sanquin (Amsterdam) and the Medical Centre
Alkmaar on severe tree nut allergies, in the period
from 1980–2005. The medical history and diagnostic
tests were carefully recorded by the physician and
retrieved retrospectively for this study. The patients
from the UK were part of the serum collection of C.
Summers and R. Pumphrey, who also had detailed his-
tories recorded. A summary of the different diagnostics
performed with these sera is outlined in Figure 1.
Severity of recorded allergic reactions was classified
into five categories, essentially following the Mueller
procedure for venom allergies [29] and adapted amongst
others by M. Fernandez-Rivas for food allergy. Grade 0
included local oropharyngeal reactions, known as oral
allergy syndrome (OAS). Grades 1 to 4 were applied to
systemic reactions: grade 1, skin involvement without
angioedema; grade 2, skin involvement with angioedema
and/or gastrointestinal symptoms; grade 3, any of the
previous with respiratory symptoms; grade 4, any of the
previous with cardiovascular symptoms. For dichotom-
ous statistical analyses, grade 1–4 were taken together in
one category systemic, opposed by grade 0 being local.
Information on the severity of the reaction to hazelnut
was available for 78/91 patients.
SPT were carried out following EAACI guidelines [30].
An SPT was considered positive if the mean wheal
diameter was 3 mm (over the negative control) or the
ratio to histamine wheal was ≥0.5. Hazelnut SPT data
were available for 65/91 patients.
Ethical approval for the study was available in each of
the participating centres.
Hazelnut extracts
Unroasted hazelnuts were bought at a local food store.
Non-defatted hazelnut extract was prepared as described
previously [17]. Defatted hazelnut extract was made by
shaking ground hazelnuts (3 times) with 30% (v/v) freon
141b NP (Promosol, Brussels, Belgium) for 1 hour and
centrifugation for 20 minutes at 11,000 g before extraction
like above. The commercially available SPT extracts used
have been characterized and described previously [17]
and were purchased from nine manufacturers: (A) ALK-
Abello’ (Nieuwegein, The Netherlands), (B) Allergopharma
(Reinbeck, Germany), (C) Allergy Laboratories of Ohio
(Columbus, Ohio, USA), (D) Stallergènes, (Antony, France),
(E) Artu Biologicals Europe, (Lelystad, The Netherlands), (F)
Bayer (Elkhart, Ind., USA), (G) Greer Laboratories, (Lenoir,
N.C., USA), (H) HAL Allergenen Lab. (Haarlem, The
Figure 1 Flowchart indicating the source of the sera and which experiments they were used. If sera were used for blotting experiments,
the serum numbers are indicated.
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N.Y., USA). All reagents were purchased as ready-for-use
products and were diluted to a concentration of 250 μg/
ml for immunoblots. For spiking experiments, extract D
was used with or without approximately 5 μg OAPs.
Oil body isolation
An oil body-enriched fraction was purified from hazel-
nut combining several methods described before [26,31].
Unroasted hazelnuts were bought at a local food store
and ground 1:2 w/v in grinding buffer (GB; 1 mM
EDTA, 10 mM KCl, 1 mM MgCl2, 2 mM DTT, 0.15 M
tricine, 0.6 M sucrose, pH 7.5 with KOH) using a
Waring blender (Waring commercial, Hartford, CT) for
approximately 5′. The extract was filtered using rough-
mazed gauze (HG Kompressen, Klinion) and layered
with 1:1 v/v flotation medium (FB; GB with 0.4 M sucro-
se). After centrifugation (30′ at 10.000 × g) the fat pad
was resuspended in detergent washing solution (GB butwith 0.2 M sucrose, 0.1% Tween-20, 75 mM tricine)
and layered with 1:1 v/v 150 mM Tricine (pH 7.5).
After centrifugation, the fat pad was re-suspended in re-
suspension buffer (RB; GB containing 2 M NaCl), layered
with 1:1 v/v floating medium (RB containing 0.25 M su-
crose) and centrifuged. The resulting fat pad was re-
suspended in 9 M urea, mixed at RT for 10′, layered with
1:1 v/v 150 mM tricine (pH 7.5) and centrifuged as previ-
ously. The fat pad was re-suspended in GB, layered with
1:1 v/v FB and centrifuged. Finally, the fat pads were re-
suspended in GB to a concentration of 100 mg lipid/ml.Defatting of oil-bodies
In order to purify oil body-associated proteins from the
oil body enriched fraction, the oil bodies were defatted
according to the method previously described [32]. After
the last separation, the interphase was dried o/n in a
fumehood before dissolving in PBS (precipitate remains).
Figure 2 Coomassie stained gels. A; natural hazelnut OAP fraction.
Indicated are the bands identified by mass-spectrometry. (1) con-
tained little amounts of both oleosins, but the main constituent
remained unidentified, (2) 11S globulin (AAL73404, Cor a 9) and (3)
and (4) mainly consisted of both oleosins, AY224679 (Cor a 12) being
the most abundant. In addition, a protein with similarity to caleosins
was detected in these bands. B; Purified recombinant oleosin Cor a
12. Marker sizes are indicated.
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associated protein) fraction.Production of antibodies
For polyclonal antibody production, New Zealand White
rabbits were immunized with ~50 μg purified hazelnut
OAP fraction in Montanide ISA-50 (Seppic, Paris, France).
The oil body fraction was filtered (Schleicher and Schuell,
New Hampshire, USA) then both fractions were dialyzed to
PBS and mixed 1:1 with 6.25% glycerol. Boosters were given
at 4 week intervals. Plasma was collected at day 7, 9 and 11
(after boosters 4, 5 and 6), re-calcified and antibody titers
were measured by RAST with Sepharose-coupled natural
hazelnut OAPs. Rabbits’ sera were pooled and stored frozen
at −20°C.Expression and purification of recombinant oleosin
Hazelnut-derived cDNA was used in a PCR with primers
based on the published sequences of both hazelnut oleosinisoforms (primary accession numbers Q84T91 and
Q84T21 [27]). After ligation of the fragments into the
pET19b expression vector (Novagen, Merck, kGaA,
Darmstadt, Germany) the sequence of the clones was con-
firmed (BaseClear Lab services, Leiden, The Netherlands).
Both recombinant hazelnut oleosins (AY224679 and
AY224599, Cor a 12 and Cor a 13 respectively) were
expressed in E.coli BL21 (DE3), in MagicMedia™ (Invitrogen,
Carlsbad, CA, US). Since they were found to be predomin-
antly in inclusion bodies, both isoforms were denatured by
addition of 6 M guanidin-HCl and purified via Ni+- chelate
affinity chromatography using a HIS-trap HP 1 ml column
(GE Healthcare, Little Chalfont, Buckinghamshire, UK).
Elution was performed with a linear gradient from 20–
500 mM imidazole. The oleosins eluted in one main peak
at a concentration of 300 mM imidazole and were first pre-
cipitated with ethanol [33] to remove the imidazole and
then dissolved in water. As we did not manage to isolate
significant amounts of Cor a 13, only Cor a 12 was used for
the inhibition experiment.SDS-PAGE/immunoblotting
SDS-PAGE and immunoblotting were performed as de-
scribed before [11] with 100 μL human serum and horse-
radish peroxidise (HRP)-labelled goat anti-human IgE
(KPL, Gaithersburg, MD, USA) as secondary antibody.
Rabbit anti-OAPs was diluted 1:11.000 in PBS/10 mM
EDTA/0.3% BSA/0.1% Tween-20, and detection was done
with radio-labelled sheep antibodies against rabbit IgG,
as described previously [34]. For blot inhibition studies,
100 μL of the inhibitor (10 μg/ml) was added together with
the patient’s serum.
Basophil histamine release assay (BHR)
BHR was carried out using the so-called stripped baso-
phil protocol as described earlier [35,36]. In short, white
blood cells were isolated from blood of a non-allergic
donor by Percoll centrifugation and stripped from IgE
by lactic acid treatment. Subsequently cells were re-
sensitized with patient’s serum. Histamine release was
performed with a dilution series of the OAP fraction.
Histamine was measured by the fluorometric method es-
sentially as described by Siraganian [37]. Stripped cells
were used as a negative control. As positive control anti-
IgE was used. The protocol was approved by the medical
ethical committee (MEC) of the Amsterdam Medical
Centre under project number: MEC97/030.
RAST
For application in RAST, 3 ml of the water-soluble part of
the OAP fraction (approximately 25 μg/ml as determined
using the Pierce BCA protein assay (Pierce, Rockford, IL)
was coupled to 100 mg CNBr-activated Sepharose 4B
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was performed as described previously [38].ImmunoCAP
CAP analysis was performed using the UniCAP®100 ac-
cording to the manufacturer’s instructions (Thermo
Fisher Scientific, Uppsala, Sweden).ESI-QTOF mass spectrometry
Identification of protein bands was performed by LC-
MS/MS after separation of OAP fraction by SDS-PAGE.
Bands were excised from CBB R-250 stained 15% poly-
acrylamide gels and in-gel digested using the ProteoEx-
tract All-In-One Trypsin Digestion Kit (Calbiochem, San
Diego, USA). Resulting peptides were separated by re-
versed phase capillary HPLC (Nanoease Symmetry 300
trap column and Nanoease Atlantis dC18 separating
column, connected via a ten-port stream select valve;
Micromass-Waters, Milford, USA). The flow rate was
adjusted to 300 nL/min by T-splitting. Peptides were
eluted with an ACN gradient (solvent A: 0.1% v/v formic
acid/5% v/v ACN, solvent B: 0.1% v/v formic acid/
95% v/v acetonitril; 5–45% B in 90 min) and directly
infused into a Global Ultima Q-Tof instrument with
electrospray ionization (Micromass QT of Global Ultima
mass spectrometer, Waters, Milford, USA). For se-
quence analysis, the instrument was calibrated with
the fragment ions of [Glu]-Fibrinopeptide B (Sigma,
Steinheim, Germany). Data were acquired in the Data
Directed Analysis (DDA) mode. Survey and fragment spec-
tra were analyzed using the software PLGS version 2.2.5
(Waters) with automatic and manual data verification. For
sequence identification, a combined Swiss-Prot/TrEMBL
database was used.Figure 3 Immunoblot showing reactivity of hazelnut allergic patients
days exposure of selected sera. Sera tested in histamine release are indicate
sizes in kDa are indicated on the sides.Statistical analysis of clinical data
Qualitative variables (gender, atopic dermatitis and re-
spiratory allergies) are presented as frequency (percent).
For quantitative variables such as hazelnut CAP and
oleosin RAST median and interquartile range (IQR) are
given. Nonparametric correlations (Spearman’s rho) be-
tween severity grade and hazelnut CAP and oleosin
RAST were calculated. For univariate and multivariate
analysis clinical severity was dichotomised as local
(grade 0) or systemic (grades 1 + 2 + 3 + 4). In the uni-
variate analysis the association between severity and the
clinical variables, hazelnut CAP and OAP RAST was
analysed by chi-square test. Associations with p-values
below 0.10 from the univariate analysis were further
analyzed in a logistic regression model to predict sys-
temic reactions. Association between SPT (positive/nega-
tive) and the OAP RAST (positive/negative) was analysed
by chi-square test. Calculations were performed using SPSS
(version 15, SPSS Inc., 2001, Chicago, USA). P-values <0.05
were considered significant.Results
Purification of OAP from hazelnut
The OAP fraction of hazelnut was analyzed by SDS-
PAGE (Figure 2A). Three major protein bands were
detected around 14, 17 and 27 kDa, respectively. In
addition, there was a minor band at ~24 kDa and un-
clear bands of higher molecular weight. LC/MS-MS
analysis identified the 14 and 17 kDa bands to be pre-
dominantly oleosins (Cor a 12 and Cor a 13) with traces
of caleosin. The main constituent of the 27 kDa band
could not be identified, but it also contained traces of
both oleosins, presumably migrating as dimers. The faint
24 kDa band was found to contain an 11S globulin sub-
unit (AAL73404, Cor a 9).’ sera to the natural hazelnut OAP fraction. A; 5′ exposure, B; 3
d with a horizontal line above the serum nr. LC, label control. Marker
Figure 4 Immunoblot-inhibition: Two identical immunoblots
loaded with (N): nOAP fraction and (R1): rCor a 12. The nature of
the inhibitor is indicated above. Detection with a hazelnut-allergic
patient’s serum (serum nr. 9, also in Figures 2 and 6). The marker
sizes are indicated, the exposure time was identical.
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immunoblot
A panel of 91 sera was tested for IgE-reactivity to the
OAP fraction in RAST. 36/91 had sIgE > 0.35 kU/L with
a mean IgE-reactivity of 6.3 kU/L (ranging from 0.35-
35.1 kU/L). To establish which constituents of the OAPFigure 5 Basophil histamine release experiment. A; mean values (+/- st
the OAP fraction. B; The histamine release from 3/14 individual sera that onfraction were recognized by IgE, all available sera with a
sIgE > 1 kU/L (n = 21) were also analysed by immunoblot
with the OAP fraction. In the OAP fraction, 15 sera
clearly recognized the 17 kDa oleosin band (Figure 3A).
At longer exposure, an additional 5 sera recognized the
oleosin band (Figure 3B). Around 11/21 were selectively
reactive with the 17 kDa band (see Figure 2A).
Hazelnut oleosin Cor a 12 (AY224679) was expressed
in E.coli and purified (up to ~80% purity) (Figure 2B).
Although solubility of the recombinant protein was poor,
sufficient soluble protein was obtained to perform an
immunoblot-inhibition to further support the designa-
tion of the 17 kDa band as oleosin. To this end, serum
of a patient (asthma, eczema, and allergy to hazelnut,
other tree nuts and peanut) was selected that demo-
strated significant IgE-reactivity to OAPs (7.1 kU/L)
uniquely directed towards the 17 kDa band (serum 9/
Figure 3). IgE-binding to natural oleosin and to rCor a
12 was completely inhibited by rCor a 12 (Figure 4). To
further support the reactivity to the OAP fraction was
caused by oleosin, IgE-responses to rCor a 8 and rCor a
9 were checked by ImmunoCAP and found to be both
negative (<0.1 kU/L).
Biological activity of the OAP fraction in BHR
To test the biological activity of IgE antibodies against
OAPs, 14 sera were tested by BHR. All showed significant
histamine release up to 50-75% with OAPs, starting from
a concentration of 100 pg/ml (Figure 5A). Amongst these
14, 3 were uniquely reactive and 2 mainly reactive with
the 17 kDa oleosin band, demonstrating that IgE anti-
bodies against oleosin are biologically active (shown for 3
in Figure 5B).
OAPs in commercial hazelnut SPT reagents
Nine commercially available SPT reagents and an in-house
defatted hazelnut extract were evaluated by immunoblotandard deviation) of 14 individually tested hazelnut allergic patients to
ly/mainly showed reactivity to the Cor a 12 band on blot.
Figure 6 Immunoblot with rabbit anti-OAP. 1: natural hazelnut
OAP fraction; 2:non-defatted in-house hazelnut extract, 3: defatted
in-house hazelnut extract, 4–12: commercially available hazelnut ex-
tracts (A-I). The arrow indicates the most IgE-reactive oleosin isoform.
Marker sizes are indicated on the left hand side.
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OAPs (Figure 6). As positive controls the purified OAP
fraction and a non-defatted hazelnut extract were used.
Clearly, the 14 and 17 kDa bands were virtually absent in
all SPT reagents and the defatted in-house hazelnut extract.
The OAP fraction and to a lesser extent the non-defatted
extract were positive. Subsequently, we used 9 sera for a
spiking experiment of SPT reagent D with OAPs, all had a
convincing history of hazelnut allergy. Three of them had a
negative/borderline SPT for hazelnut, and for the remaining
6 SPT data to hazelnut were not available. Spiking of the
SPT reagent with OAPs convincingly demonstrated
that all patients strongly recognized a band slightly
under 17 kDa, and some also weakly a band of slightly
under 14 kDa, in the spiked but not in the commercial
SPT (Figure 7). These bands correspond to the mo-
lecular mass of both oleosin bands identified in the
OAP fraction. In our group of hazelnut allergic pa-
tients from which hazelnut SPT data were available
(n = 65/91) a RAST ≥0.30 kU/L to OAPs was signifi-
cantly associated with a negative SPT outcome (χ2 6.3,
p = 0.012 (0.019 using Fischer’s exact test), Figure 8B).Figure 7 Immunoblot showing IgE-reactivity of 9 patient sera to a co
spiked (lanes 2) with the hazelnut OAP fraction. Marker sizes are indicaClinical relevance of sensitization to OAPs
In order to asses whether OAPs may be associated
with more severe clinical phenotypes amongst hazelnut
allergic patients (n = 91), we performed univariate and
multivariate regression analysis, using the clinical char-
acteristics summarized in Table 1. Hazelnut Immuno-
CAP values were available for 84/91 subjects with a
median value of 2.0 kU/L (IQR 0.5-7.03 kU/L). RAST to
the OAP fraction was performed in all of them with a
median value of 0.13 IU/ml (IQR 0.07-2.25 IU/ml). The
hazelnut CAP and the OAP RAST increased with the se-
verity of the reported reaction (from Grade 0 to 4),
and the association was significant for both: OAP RAST
(p = 0.014); hazelnut CAP (p = 0.026). When combining
grades 1 to 4 (all systemic), the association is only sig-
nificant for the OAP RAST (p = 0.032) and not for the
hazelnut CAP (p = 0.469) (Figure 8A). In the univariate
analysis associations with a p <0.10 were found between
systemic reactions and OAP RAST (χ2 6.8, p = 0.009),
pollen allergy (χ2 3.8, p = 0.07), and allergic rhinitis (χ2
3.0, p = 0.08). However, in the logistic model only the
OAP RAST was independently associated with systemic
reactions with an OR 4.24 (95% confidence interval
1.34-14.62, p 0.015).
Discussion
The first oleosin identified as food allergen was peanut
oleosin[26], followed by sesame oleosin[16]. Using a
cDNA library screening approach, we reported the pre-
liminary identification of hazelnut oleosins, Cor a 12
and Cor a 13 as allergens [27]. Here we report the isola-
tion of a natural OAP fraction from hazelnut and dem-
onstrate that the 14 and 17 kDa bands therein are
oleosins. The 17 kDa band is recognized by IgE anti-
bodies of the majority of a cohort of hazelnut allergic
patients. This was supported by mass spectrometric
identity confirmation of both 14 and 17 kDa bands and
by complete inhibition of IgE binding to the 17 kDa
band by rCor a 12. Surprisingly, specific peptides hom-
ologous to the reported sequences of both the 14.7 kDa
(Cor a 13) and 16.7 kDa (Cor a 12) isoforms of hazelnut
oleosin were identified in both 14 kDa and 17 kDammercially available hazelnut extract (D) unspiked (lanes 1) or
ted at both sides; NA: non-atopic control serum; LC: label control.
Figure 8 Correlations between severity grade, hazelnut CAP, OAP RAST and SPT. A; Correlation between severity grade (grade 0 vs grade
1–4 combined) and hazelnut CAP or OAP RAST. B; Correlation between OAP RAST (cut-off 0.3 kU/L) and SPT (pos/neg).
Zuidmeer-Jongejan et al. Clinical and Translational Allergy 2014, 4:4 Page 8 of 10
http://www.ctajournal.com/content/4/1/4bands. It can therefore not be ruled out that oleosin iso-
forms exist in long and truncated variants. The detection
of oleosin in the 27 kDa band suggests that hazelnut
oleosins also exist as dimers. This has been described
before by Li and co-workers [39] who showed that iden-
tical oleosin molecules can self-associate, both in vitro
and in vivo, to form homo-oligomers.
Oleosins are highly hydrophobic and consequently,
once taken out of their oil body environment, poorly sol-
uble proteins. This was observed when isolating OAPsTable 1 Descriptive statistics of our patient panel (n = 91)
Sex (N =90, 1 missing)
Male 45 (50%)
Female 45 (50%)
Severity of reactions (N =78, 13 missing)
Grade 0 27 (34.6%)
Grade 1 11 (14.1%)
Grade 2 25 (32.1%)
Grade 3 11 (14.1%)
Grade 4 4 (5.1%)




Atopic dermatitis 57/81 (70.4%)
Allergic rhinitis 59/81 (72.8%)
Allergic asthma 65/82 (79.3%)
Respiratory allergy (rhinitis and/or asthma) 75/81 (92.6%)
Birch pollen allergy 57/66 (86.4%)
Grass pollen allergy 57/68 (83.8%)
Pollen allergy (grass and/or birch) 64/71 (90.1%)and when purifying rCor a 12 produced in E.coli. Poor
solubility hampers accurate evaluation of the immune-
reactivity of oleosins. In the present study, we have
nevertheless succeeded in establishing the allergenicity
of OAPs, and confirming an important role of oleosin as
oil body associated major allergen. The hydrophobic na-
ture of OAPs such as oleosins also explains their virtual
absence in commercial SPT reagents, them being exten-
sively defatted during their production. The low sensitiv-
ity for detection of OAPs may be at the basis of false-
negative SPT in patients with a convincing history of
hazelnut allergy. It is of great importance to develop sol-
uble recombinant oleosin reagents that can be used for
diagnostic purposes, e.g. for spiking current diagnostic
hazelnut extracts used for in vitro diagnosis as has been
successfully done with rCor a 1 [40]. We are currently
working on several strategies to obtain well folded and
soluble recombinant reagents, including the production
of soluble domains and the use of conjugated highly sol-
uble carrier proteins. Hopefully, these approaches will
allow us to firmly establish the role oleosins play in se-
vere allergies to legumes, nuts and seeds.
In this study we have for the first time demonstrated
in a group of 91 hazelnut allergic patients that OAPs are
significantly and independently associated with systemic
reactions to hazelnut, with an OR 4.24 (95% confidence
interval 1.34-14.62, p = 0.015). We can not claim with
great certainty that (only) oleosins are at the basis of this
association, because minor contaminations with Cor a 9
were detected. Indeed some sera showed clear IgE binding
at higher molecular mass, potentially pointing towards Cor
a 9 recognition. In this study, in most cases we did not have
sufficient serum to also analyze IgE responses to other
hazelnut allergens such as Cor a 9, an allergen that has
been demonstrated to be associated with more severe
hazelnut allergy [13]. Another potential limitation of our
Zuidmeer-Jongejan et al. Clinical and Translational Allergy 2014, 4:4 Page 9 of 10
http://www.ctajournal.com/content/4/1/4findings is the retrospective and non-standardized collec-
tion of clinical information by different clinical groups, with
only 30/91 having DBPCFC-confirmed hazelnut allergy
(one of these with mono-sensitization to oleosin on blot).
In order to further support the association of oleosin-
specific IgE with severe symptoms, purified oleosin has
been integrated into the large European multi-center
study on component resolved diagnosis of food aller-
gies, EuroPrevall [41]. EuroPrevall has a serum collection
of over seven hundred well characterized hazelnut-allergic
patients from 12 European countries of which 128 have
been challenged by DBPCFC (90 positive) and an additional
22 had anaphylactic reactions. As soon as sufficient purified
and/or soluble recombinant allergen is available, the
EuroPrevall serum bank [42] will provide us the oppor-
tunity to establish the importance of oleosin for hazel-
nut allergic patients, to study cross-reactivity to other
nuts, legumes and seeds, and to further investigate the
importance of sensitization to oleosins in regard to the
severity of clinical symptoms. In EuroPrevall, all serum
samples have already been tested on a battery of hazel-
nut components including rCor a 9 (11S) and rCor a
14 (2S). Moreover, demographic and clinical data have
been collected in a standardized fashion. Together this
will allow us to firmly establish whether oleosins are
indeed a risk factor for severe hazelnut allergy, inde-
pendent from Cor a 8 [7], Cor a 9 and/or Cor a 14 [13].
This will guide us on how to further improve allergy
diagnostics.
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